These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 19111385)

  • 1. Precursor isoform of prostate-specific antigen and human kallikrein 2: two new promising biomarkers for the unsolved challenge of early prostate cancer detection.
    Ficarra V; Novara G; Galfano A
    Eur Urol; 2009 Mar; 55(3):556-9. PubMed ID: 19111385
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer in 2008 II: the importance of molecular subforms of prostate-specific antigen and tissue kallikreins.
    Jansen FH; Roobol M; Jenster G; Schröder FH; Bangma CH
    Eur Urol; 2009 Mar; 55(3):563-74. PubMed ID: 19058905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSA and other tissue kallikreins for prostate cancer detection.
    Stephan C; Jung K; Lein M; Diamandis EP
    Eur J Cancer; 2007 Sep; 43(13):1918-26. PubMed ID: 17689069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancer.
    Karazanashvili G; Abrahamsson PA
    J Urol; 2003 Feb; 169(2):445-57. PubMed ID: 12544286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen kallikrein and acute myocardial infarction: where we are. Where are we going?
    Patanè S; Marte F
    Int J Cardiol; 2011 Jan; 146(1):e20-2. PubMed ID: 19185931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen dynamics and prostate cancer diagnosis.
    Bartoletti R
    Eur Urol; 2009 Nov; 56(5):761-2; discussion 763. PubMed ID: 19665286
    [No Abstract]   [Full Text] [Related]  

  • 7. Biomarkers for prostate cancer detection.
    Parekh DJ; Ankerst DP; Troyer D; Srivastava S; Thompson IM
    J Urol; 2007 Dec; 178(6):2252-9. PubMed ID: 17936845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.
    van Gils MP; Stenman UH; Schalken JA; Schröder FH; Luider TM; Lilja H; Bjartell A; Hamdy FC; Pettersson KS; Bischoff R; Takalo H; Nilsson O; Mulders PF; Bangma CH
    Eur Urol; 2005 Dec; 48(6):1031-41. PubMed ID: 16054748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are multiple markers the future of prostate cancer diagnostics?
    Mikolajczyk SD; Song Y; Wong JR; Matson RS; Rittenhouse HG
    Clin Biochem; 2004 Jul; 37(7):519-28. PubMed ID: 15234233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers for prostate cancer.
    Makarov DV; Loeb S; Getzenberg RH; Partin AW
    Annu Rev Med; 2009; 60():139-51. PubMed ID: 18947298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advances in proPSA on early detection in prostate cancer].
    Zhu PY; Hong P; Huang YF
    Zhonghua Nan Ke Xue; 2005 Dec; 11(12):944-6. PubMed ID: 16398372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.
    Mabjeesh NJ; Amir S; Stenger A; Chen J; Matzkin H
    Prostate; 2009 Aug; 69(11):1235-44. PubMed ID: 19434652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total, free and complexed PSA and hK2 for early detection of prostate cancer.
    Haese A; Khan MA; Sokoll LJ
    MLO Med Lab Obs; 2003 Jun; 35(6):14-6, 20, 22 passim; quiz 30-1. PubMed ID: 12841068
    [No Abstract]   [Full Text] [Related]  

  • 14. Validity and legacy of prostate-specific antigen (PSA) and PSA-based parameters and isoforms in the new millennium.
    Djavan B
    Eur Urol; 2010 Jun; 57(6):928-9. PubMed ID: 20304552
    [No Abstract]   [Full Text] [Related]  

  • 15. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
    Väisänen V; Peltola MT; Lilja H; Nurmi M; Pettersson K
    Anal Chem; 2006 Nov; 78(22):7809-15. PubMed ID: 17105175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hK2, free PSA, and complexed PSA measurements in the very early detection of prostate cancer.
    Lilja H
    Eur Urol; 2001 Apr; 39 Suppl 4():47-8. PubMed ID: 11340291
    [No Abstract]   [Full Text] [Related]  

  • 17. Medical technologies for the diagnosis of prostate cancer.
    Fitzsimons NJ; Sun L; Moul JW
    Expert Rev Med Devices; 2007 Mar; 4(2):227-39. PubMed ID: 17359227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection.
    Schostak M; Schwall GP; Poznanović S; Groebe K; Müller M; Messinger D; Miller K; Krause H; Pelzer A; Horninger W; Klocker H; Hennenlotter J; Feyerabend S; Stenzl A; Schrattenholz A
    J Urol; 2009 Jan; 181(1):343-53. PubMed ID: 19012935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate-specific antigen kallikrein is not a marker of non-ST elevation acute coronary syndrome.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Hernandez-Garcia C; Tome MC; Lara-Padron A
    Int J Cardiol; 2011 May; 149(1):141-2. PubMed ID: 21371763
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostate specific antigen.
    Brett T
    Aust Fam Physician; 2011 Jul; 40(7):497-500. PubMed ID: 21743854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.